| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/24/1997 | CN1035938C Substd. (arylalkoxybenzyl) aminopropanamide derivs. their preparation method |
| 09/24/1997 | CN1035925C Method for preparation of cytotropic non-homogeneous molecular lipid |
| 09/24/1997 | CN1035923C Method for preparing lipophilic oligosaccharide antibiotics composition |
| 09/24/1997 | CN1035922C Method for preparing transdermally applied dexmedetomidine system |
| 09/23/1997 | US5670699 Process for preparing amino acid esters useful as intermediates for compounds containing a fused bicyclic ring |
| 09/23/1997 | US5670695 Process for the preparation of diacerein |
| 09/23/1997 | US5670684 Process and intermediates for the preparation of excitatory amino acid receptor antagonists |
| 09/23/1997 | US5670675 Retroviral protease inhibiting compounds |
| 09/23/1997 | US5670640 Chemical condensation and cyclization using alkyllithium, alkoxides, lithium hexamethyldisilazide |
| 09/23/1997 | US5670638 2-bromo- and 2-nitroxy derivatives of 3-bromo- and 3,3-dibromo-4-oxo-azetidines, and preparation |
| 09/23/1997 | US5670637 Binding to target molecules; antibodies |
| 09/23/1997 | US5670634 Inhibit expression of peptide of alzheimer's disease and down's syndrome |
| 09/23/1997 | US5670633 Sugar modified oligonucleotides that detect and modulate gene expression |
| 09/23/1997 | US5670549 Prevention and amelioration of liver toxicity with beta-carotene |
| 09/23/1997 | US5670547 Moisturizing vehicle for topical application of vitamin A acid |
| 09/23/1997 | US5670546 N-Arylalkylphenylacetamide derivatives |
| 09/23/1997 | US5670545 Cardiovascular disorders |
| 09/23/1997 | US5670544 Substituted benzoylguanidines process for their preparation their use as a medicament or diagnostic and medicament containing them |
| 09/23/1997 | US5670543 Skin disorders and aging resistance |
| 09/23/1997 | US5670542 Topical application |
| 09/23/1997 | US5670541 Skin treatment with hydroxy acids |
| 09/23/1997 | US5670540 Triglycerides of fatty acids |
| 09/23/1997 | US5670539 Treatment of movement disorders using large neutral amino acids |
| 09/23/1997 | US5670538 Use of prodelphinidins for obtaining medicaments intended for the treatment of arthrosis |
| 09/23/1997 | US5670537 Method for effecting tumor regression with a low dose, short infusion taxol regimen |
| 09/23/1997 | US5670536 Pharmaceutical composition based on taxoids |
| 09/23/1997 | US5670535 Thiophene compounds |
| 09/23/1997 | US5670530 Anti-cancer composition comprising rhodacyanine compound and cyclodextrin |
| 09/23/1997 | US5670527 Cytokine inhibitors useful in treating asthma, osteoporosis, arthritis, inflammation, sepsis, cardiovascular disorders, diabetes, multiple sclerosis, skin disorders |
| 09/23/1997 | US5670525 Substituted 4-phenyl-6-amino-nicotinic acid compounds useful in the treatment of CNS disorders |
| 09/23/1997 | US5670524 Methods and compositions for the treatment of pain utilizing ropivacaine |
| 09/23/1997 | US5670523 Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) |
| 09/23/1997 | US5670522 Fused ring heterocycle, treatment of schizophrenia |
| 09/23/1997 | US5670521 Antitumor agents for drug resistant tumors |
| 09/23/1997 | US5670520 Method for inhibiting virus replication in mammalian cells using carbostyil derivatives |
| 09/23/1997 | US5670519 Acenaphthyl-substituted guanidines and methods of use thereof |
| 09/23/1997 | US5670518 Antitumor agents; viricides |
| 09/23/1997 | US5670516 Excitatory amino acid receptor antagonists |
| 09/23/1997 | US5670515 Amino acid derivatives |
| 09/23/1997 | US5670514 Benzoquinolin-3-one |
| 09/23/1997 | US5670513 Medicinal feed for the systemic treatment of ectoparasitic and ectobacterial diseases of fish |
| 09/23/1997 | US5670512 Skin disorders; reductase inhibitors |
| 09/23/1997 | US5670511 Indolepiperidine derivatives |
| 09/23/1997 | US5670507 Antitumor agents and anticarcinogenic agents |
| 09/23/1997 | US5670505 Tachykikin antagonist for respiratory diseases, ophthalmic diseases and antiinflammatory agents |
| 09/23/1997 | US5670504 2,6-diaryl pyridazinones with immunosuppressant activity |
| 09/23/1997 | US5670503 Prophylactic and therapeutic treatment of interleukin-1 and tumor necrosis factor mediated diseases such as inflammatory diseases, autoimmune diseases |
| 09/23/1997 | US5670502 Method of tumor treatment |
| 09/23/1997 | US5670501 Useful as diuretics, treating renal disorders, restoring cardiac functions |
| 09/23/1997 | US5670500 Water soluble camptothecin analogs |
| 09/23/1997 | US5670499 Physiological disorders, gastrointestinal disorders, antiinflammatory agents |
| 09/23/1997 | US5670497 Cyclic hydrazine compounds |
| 09/23/1997 | US5670496 Treatment for toxoplasmosis with a composition comprising a folate antagonist and a spiropiperidyl derivative of rifamycin S |
| 09/23/1997 | US5670495 Method of pretreating an animal with a corticosteroid prior to infusion of a perfluorochemical emulsion |
| 09/23/1997 | US5670494 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors |
| 09/23/1997 | US5670493 Angiogenesis inhibitors |
| 09/23/1997 | US5670491 Photodynamic chemotherapy of tumors |
| 09/23/1997 | US5670489 Oligonucleotide analogues |
| 09/23/1997 | US5670485 Anticoccidial methods and feedstuffs |
| 09/23/1997 | US5670361 HIV-specific ribozymes |
| 09/23/1997 | US5670191 Aliphatic amide feed supplement for ruminants |
| 09/23/1997 | US5670177 Injectable NO/CO2 gaseous mixture |
| 09/23/1997 | US5670176 Dialysis solution |
| 09/23/1997 | US5670172 Pharmaceutical spheroid formulation |
| 09/23/1997 | US5670171 Liquid-suspension controlled-release pharmaceutical composition |
| 09/23/1997 | US5670170 Effervescent couple; antibiotic suspension |
| 09/23/1997 | US5670164 Nitroglycerin-containing patch, a process for the production and the use thereof |
| 09/23/1997 | US5670158 Bisacodyl dosage form |
| 09/23/1997 | US5670144 Anti-herpes virus and cytomegalovirus polyester oligomers |
| 09/23/1997 | US5670143 Anti-HIV pharmaceutical formulations |
| 09/23/1997 | CA2172479A1 Immunomodulating active substance |
| 09/23/1997 | CA2069024C Processes for the diastereoselective synthesis of nucleosides |
| 09/23/1997 | CA2045857C Diaminotrifluoromethylpyridine derivatives, process for their production and phospholipase a2 inhibitor containing them |
| 09/22/1997 | CA2200163A1 Antithrombotic diamides |
| 09/22/1997 | CA2193579A1 Chemoprevention of metachronous adenomatous colorectal polyps |
| 09/21/1997 | CA2199859A1 4-thia-1-azabicyclo/3.2.0/heptane-3-imino-2-isopropylidene-7-oxo analogons of beta-lactams, processes for their preparation and the use thereof |
| 09/20/1997 | CA2200394A1 A pharmaceutical preparation for treating blood coagulation disorders |
| 09/20/1997 | CA2200385A1 1,3,5-trisubstituted indazole derivatives, processes for preparing, and for pharmacological treatment therewith |
| 09/20/1997 | CA2200175A1 2-aryl-substituted pyridines |
| 09/20/1997 | CA2199923A1 Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors |
| 09/19/1997 | CA2199925A1 Fluoroalkyl- and fluoroalkoxy-substituted heterocyclic bradykinin antagonists, process for their preparation, and their use |
| 09/18/1997 | WO1997034137A2 Methods of the identification of pharmaceutically active compounds |
| 09/18/1997 | WO1997034009A1 Recombinant adenoviral vectors for human tumour gene therapy |
| 09/18/1997 | WO1997034002A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/18/1997 | WO1997034001A1 Clostridium perfringens vaccines |
| 09/18/1997 | WO1997033999A1 Immunity to trypanosomatids species |
| 09/18/1997 | WO1997033998A1 Targeted delivery of genes encoding interferon |
| 09/18/1997 | WO1997033997A1 Method of treating muscular disorders |
| 09/18/1997 | WO1997033995A2 Extracellular matrix signalling molecules |
| 09/18/1997 | WO1997033991A1 Short external guide sequences |
| 09/18/1997 | WO1997033980A1 Transgenic animals having a disrupted endothelial nitric oxide synthase gene and methods of use |
| 09/18/1997 | WO1997033912A2 Uses of gdnf and gdnf receptor |
| 09/18/1997 | WO1997033911A1 Persephin and related growth factors |
| 09/18/1997 | WO1997033910A1 Immunomodulatory peptides of vespid antigen 5 |
| 09/18/1997 | WO1997033902A1 Human tumor necrosis factor delta and epsilon |
| 09/18/1997 | WO1997033901A1 Smooth muscle cell lim protein |
| 09/18/1997 | WO1997033896A1 Polyvalent polymers for the treatment of rotavirus infection |
| 09/18/1997 | WO1997033894A1 Binuclear platinum complexes, method for preparing same and pharmaceutical compositions containing said complexes |
| 09/18/1997 | WO1997033889A1 NOVEL IMIDAZO[1,5-c]QUINAZOLINES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS |
| 09/18/1997 | WO1997033887A1 Spirocycle integrin inhibitors |